Hydrogels are promising candidates for delivering antibacterial agents to site of infection owing to their multitude of advantages such as controlled release, biocompatible nature, water retention capacity. We have explored our biomaterials research spectrum by developing polymeric hydrogels which have shown the potential of treating skin tissue infections in-vivo. Such approach can be useful to prevent surgical site infections, one of the major hospital-acquired infections claiming a high number of lives worldwide. We have also engineered release-active hydrogels which can tackle eye infections. Our formulations can also act as tissue-adhesive and prevent blood loss.
